Jeong Sig Kim

684 total citations
11 papers, 559 citations indexed

About

Jeong Sig Kim is a scholar working on Molecular Biology, Pharmacology and Epidemiology. According to data from OpenAlex, Jeong Sig Kim has authored 11 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Epidemiology. Recurrent topics in Jeong Sig Kim's work include Autophagy in Disease and Therapy (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Cannabis and Cannabinoid Research (2 papers). Jeong Sig Kim is often cited by papers focused on Autophagy in Disease and Therapy (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Cannabis and Cannabinoid Research (2 papers). Jeong Sig Kim collaborates with scholars based in South Korea, United States and Singapore. Jeong Sig Kim's co-authors include Hwan‐Woo Park, Haeli Park, Jun Hee Lee, Ian Semple, Myungjin Kim, Seung‐Hyun Ro, Insook Jang, Haewon Park, Jung‐Jae Kim and Edward L. Stuenkel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Scientific Reports.

In The Last Decade

Jeong Sig Kim

9 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeong Sig Kim South Korea 6 300 221 128 75 53 11 559
Yue Zong China 7 506 1.7× 196 0.9× 73 0.6× 96 1.3× 181 3.4× 9 777
Shu Zhuo China 15 326 1.1× 138 0.6× 199 1.6× 91 1.2× 64 1.2× 22 674
Jin‐Feng Zhao United Kingdom 14 279 0.9× 104 0.5× 28 0.2× 56 0.7× 50 0.9× 26 477
Jessica Díaz‐Elizondo Chile 9 231 0.8× 119 0.5× 76 0.6× 64 0.9× 26 0.5× 11 404
Johan Bourghardt Fagman Sweden 11 282 0.9× 154 0.7× 79 0.6× 55 0.7× 165 3.1× 25 716
Núria Matías Spain 8 233 0.8× 285 1.3× 76 0.6× 128 1.7× 65 1.2× 12 562
Somashubhra Bhattacharya United States 6 262 0.9× 352 1.6× 96 0.8× 92 1.2× 76 1.4× 7 606
Weinong Han United States 11 349 1.2× 161 0.7× 59 0.5× 51 0.7× 19 0.4× 18 627
Zuo Wang China 11 242 0.8× 123 0.6× 40 0.3× 53 0.7× 69 1.3× 15 484

Countries citing papers authored by Jeong Sig Kim

Since Specialization
Citations

This map shows the geographic impact of Jeong Sig Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeong Sig Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeong Sig Kim more than expected).

Fields of papers citing papers by Jeong Sig Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeong Sig Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeong Sig Kim. The network helps show where Jeong Sig Kim may publish in the future.

Co-authorship network of co-authors of Jeong Sig Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Jeong Sig Kim. A scholar is included among the top collaborators of Jeong Sig Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeong Sig Kim. Jeong Sig Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Lyu, Jungmook, Jong-Seok Kim, Jongdae Shin, et al.. (2023). Methylsulfonylmethane ameliorates metabolic-associated fatty liver disease by restoring autophagy flux via AMPK/mTOR/ULK1 signaling pathway. Frontiers in Pharmacology. 14. 1302227–1302227. 5 indexed citations
2.
Won, Gunho, Jong-Seok Kim, Ssang‐Goo Cho, et al.. (2020). mTOR-Dependent Role of Sestrin2 in Regulating Tumor Progression of Human Endometrial Cancer. Cancers. 12(9). 2515–2515. 22 indexed citations
3.
Kim, Myojeong, Eun Ji Lee, Jiyoung Hwang, et al.. (2019). Primary Pelvic Peritoneal Yolk Sac Tumor in the Post-Pubertal Female: a Case Report with Literature Review. Investigative Magnetic Resonance Imaging. 23(4). 367–367.
4.
Kim, Jeong Sig, Seung‐Hyun Ro, Myung-Jin Kim, et al.. (2015). Sestrin2 inhibits mTORC1 through modulation of GATOR complexes. Scientific Reports. 5(1). 9502–9502. 144 indexed citations
5.
Lee, Eun Sil, et al.. (2015). Avoiding unnecessary blood transfusions in women with profound anaemia. Australian and New Zealand Journal of Obstetrics and Gynaecology. 55(3). 262–267. 5 indexed citations
6.
Park, Hwan‐Woo, Haeli Park, Ian Semple, et al.. (2014). Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers. Nature Communications. 5(1). 4834–4834. 155 indexed citations
7.
Semple, Ian, Haewon Park, Haeli Park, et al.. (2014). Sestrin2 promotes Unc‐51‐like kinase 1 mediated phosphorylation of p62/sequestosome‐1. FEBS Journal. 281(17). 3816–3827. 101 indexed citations
8.
Ro, Seung‐Hyun, Myeong‐Jin Nam, Insook Jang, et al.. (2014). Sestrin2 inhibits uncoupling protein 1 expression through suppressing reactive oxygen species. Proceedings of the National Academy of Sciences. 111(21). 7849–7854. 74 indexed citations
9.
Lee, Eun Sil, et al.. (2012). Comparison of adverse event profile of intravenous iron sucrose and iron sucrose similar in postpartum and gynecologic operative patients. Current Medical Research and Opinion. 29(2). 141–147. 52 indexed citations
11.
Kim, Jeong Sig, et al.. (2012). Synergistic effects of sorafenib and celecoxib inhibit growth and VEGF expression in Hec-1A endometrial cancer cell line. Korean Journal of Obstetrics & Gynecology. 55(11). 814–814. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026